About Signals Analytics

Signals Analytics helps world leading brands uncover actionable insights from disparate data, driving smarter, more informed product decisions quicker and with less risk. Signals Playbook™ platform empowers leading companies to adopt their product decision making to the fast-changing ecosystems, by combining unique data sets, machine learning and analytic engines to provide decision support that span the entire product lifecycle. Signals Playbook™ is a cloud-based data platform that transforms diverse, unstructured and unconnected big data into smart data lakes, then extracts actionable insights that optimize product portfolio health, accelerate new product success and propel breakthrough innovation. Leading companies, including Procter & Gamble, Nestle, Johnson & Johnson, Bayer and 3M, have partnered with Signals Analytics to drive superior business outcomes.


  • Gil Sadeh


Founded: 2009

Offices: Israel, New York, and Switzerland

Additional Investors: Sequoia, TPY Capital, Pitango

Qumra Board Member: Boaz Dinte

Top news

Kenshoo to Acquire Signals Analytics to Fuel Intelligent Go-to Market

December 27, 2020

Kenshoo, a global leader in marketing technology, today announced its intent to acquire Signals Analytics, a pioneer in AI-powered analytics for market intelligence. The acquisition positions the company to solve the biggest challenge brands face in the post-COVID-19 era: How to catch up with accelerated e-commerce adoption and be best positioned to understand, engage and transact with consumers regardless of channel.

Signals Analytics Powers Informa Pharma Intelligence’s Offerings With Next Generation Advanced Analytics

April 22, 2020

Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and Signals Analytics, announced a joint offering that helps life sciences companies to identify new opportunities, mitigate investment risks and accelerate the drug development process.

Signals Analytics Announces a COVID-19 Playbook Leveraging Advanced Analytics for Accelerating Vaccine Development and Drug Discovery

March 25, 2020

Signals Analytics, the next-generation advanced analytics platform that leverages external data to uncover trends and predictive insights, today unveils its COVID-19 Playbook, providing access to critical market intelligence and trends surrounding potential treatments for the novel coronavirus.

See more